<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We carried out clinico-economical analysis of 2 tactics of rhythm restoration in patients with <z:hpo ids='HP_0004757'>paroxysmal atrial fibrillation</z:hpo> (AF) lasting less than 48 hours: cardioversion at prehospital stage with intravenous <z:chebi fb="0" ids="8428">procainamide</z:chebi> and inhospital cardioversion with any method </plain></SENT>
<SENT sid="1" pm="."><plain>This retrospective study was based on the data from department of urgent aid of an outpatient clinic </plain></SENT>
<SENT sid="2" pm="."><plain>The results showed that within 48 hours inhospital was a was more effective, safe, and more economically profitable compared with administration of <z:chebi fb="0" ids="8428">procainamide</z:chebi> at prehospital stage </plain></SENT>
<SENT sid="3" pm="."><plain>Intravenous <z:chebi fb="0" ids="8428">procainamide</z:chebi> resulted in effective cardioversion in 70.6% of patients </plain></SENT>
<SENT sid="4" pm="."><plain>It was associated with <z:hpo ids='HP_0002615'>arterial hypotension</z:hpo> and proarrhythmogenic action in 14,7% of cases </plain></SENT>
<SENT sid="5" pm="."><plain>Patients with effective cardioversion with <z:chebi fb="0" ids="8428">procainamide</z:chebi> had lesser mean values of left ventricular anterior-posterior dimension (echocardiography) and shorter duration of <z:hpo ids='HP_0011675'>arrhythmia</z:hpo> </plain></SENT>
</text></document>